MSD
For over 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of their mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
See below for the Latest MSD News, Analysis, Profit Results, Share Price Information, and Commentary.
MSD navigates the pandemic tapestry in COVID-19 fight
MSD navigates the pandemic tapestry in COVID-19 fight
It has navigated the complexities of the challenging period through a proactive approach.
Join the community
Most Read
1. Global endoscopic closure devices market to grow by $825.7m by 2029 2. NHG names new Chairman, Medical Board of Khoo Tech Puat Hospital 3. Qatar develops advanced occupational and environmental medicine programme 4. New Communicable Diseases Agency to be set up in first half of 2025 5. AI-driven adaptive cardiac devices to improve heart disease treatmentResource Center
Awards
Apr
10
Events
Event News
Co-Written / Partner
KPMG’s Peter Liddell advocates resilient healthcare solutions
He discussed the pressing challenges and transformative solutions shaping the future of healthcare in the Asia Pacific.